April 29, 2016
Bulletin interne de l'Institut Pasteur
News - April 29, 2016
- Réseau Franco-Néerlandais (FRNL) - Bourses Eole 2016 session printemps
Objectif : accorder des bourses de mobilité destinées à des étudiants en master et à des doctorants, toutes disciplines confondues, pour un séjour d’études, de recherche ou un stage aux Pays-Bas. Ces bourses sont attribuées sur la base d’une sélection stricte des meilleurs projets.
Durée : séjours prévus de septembre 2016 à février 2017.
Montant : forfaitaire de 500 à 1000€
Deadline : 30/04/2016
- Institut National du Cancer (INCa) - Subventions doctorales 2016 Epidémiologie, Santé publique et cancer
Objectif : promouvoir des recherches en Sciences Humaines et Sociales (éthique, promotion de la santé...), Epidémiologie, Biostatistiques, santé environnement et Santé Publique dans le domaine de la lutte contre le cancer.
Durée et montant : 90 000 euros sur 3 ans.
Eligibilité : étudiants titulaires d’un master2 en SHS ou Epidémiologie ou biostatistiques ou santé‐environnement ou/Santé Publique.
Deadline : 10/05/2016
- Ministère de l'Education Nationale, de l'Enseignement Supérieur et de la Recherche (MENESR) - Contrats doctoraux handicap : campagne nationale 2016
Objectif :
1/ Favoriser la poursuite des études jusqu'au niveau le plus élevé pour les étudiants en situation de handicap ;
2/ Créer un vivier de personnes handicapées titulaires d'un doctorat pour répondre aux besoins de recrutement tant dans le milieu académique que dans les entreprises ;
Eligibilité : financement de vingt-cinq contrats à des étudiants présentant un projet de thèse et reconnus bénéficiaires de l'obligation d'emploi.
Deadline : 10/05/2016 (12:00)
- Ministère de l’éducation et de la science de la Fédération de Russie - appel à propositions dans le cadre du programme Megagrant
Objectif : Ce programme offre la possibilité à des chercheurs de conduire un projet de recherche en Russie sur plusieurs années. Toutes les disciplines scientifiques sont concernées.
Eligibilité : une proposition devra associer :
- un porteur de projet, scientifique russe ou étranger reconnu dans son domaine, et
- une institution de recherche russe
Financement et durée : 90 millions de roubles (approx. 1.200.000€) sur 3 ans (2017–2019). Une prolongation peut être accordée pour deux années supplémentaires.
Deadline : 31/05/2016 (12:00, heure de Moscou)
- Joint Programming Initiative on Antimicrobial Resistance (JPI AMR) - 4th Joint Call “Call for Transnational Networks/Working Groups within the Joint Programming Inititative on Antimicrobial Resistance”
The JPIAMR, in partnership with 8 European countries (Belgium, France, Germany, Netherlands, Norway, Spain, Sweden and the UK), and Canada, is launching a fourth joint call for working group proposals.
Purpose: to assemble motivated groups of leading experts and establish Working Groups in order to enhance resource alignment and maximise existing and future efforts to combat AMR by pushing forward the conceptualisation of ideas, in turn providing white papers, prospective views, guidelines and/or best practice/ roadmap/systematic reviews and frameworks of value to the wider research community.
Eligibility: Each transnational Working Group is expected to include partners from at least 3 participating countries.
Funding: A maximum grant of €50,000 will be awarded per selected Working Group over a 6-to-12 months’ time period. Funding will cover the cost of meetings and travel required to achieve the working group’s objectives.
Deadline : 06/06/2016 (17:00 CET)
- Pour le Brésil, l’Université de São Paulo ; pour la France, le ministère des Affaires étrangères et du Développement international (MAEDI) et le ministère de l’Education nationale, de l’Enseignement supérieur et de la Recherche (MENESR) - Programme USP-COFECUB
Objectif : permettre une collaboration sur un projet scientifique commun permettant notamment de former des docteurs brésiliens et français. Le programme est ouvert à la recherche de base dans tous les champs disciplinaires.
Durée : 2 ans, pouvant être renouvelés pour une période de deux ans.
Financement : Côté français, le COFECUB prend en charge les frais de voyage des chercheurs français vers le Brésil et les frais de séjour en France pour les Brésiliens.Côté brésilien, l’Université de São Paulo prend en charge les frais de voyage de ses chercheurs ainsi que les frais de séjour des Français.
Deadline : 08/06/2016
- National Institutes of Health (NIH) - Exploratory Grants in Cancer Epidemiology and Genomics Research (R21)
Purpose: to invite applications for research on cancer epidemiology, genomics, and risk assessment. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance cancer research, such as improving epidemiologic study data collection; validating measurement of exposures in body fluids and tissues; applying epigenetic or metabolomic approaches to cancer epidemiology research; developing and applying novel strategies for discovery of risk variants for rare cancers; understanding the population genetic architecture of cancer in understudied populations; or validating methods to extract, collect, and synthesize clinical data via electronic medical records for use in observational studies of cancer patients and survivors.
Budget and duration: The combined budget for direct costs for the two year project period may not exceed $275,000. The maximum project period is 2 years.
Application due date(s): Applications can be submitted every February 16th /June 16th/October 16th (R21 due dates) until May 8, 2019
Deadline : Plusieurs dates limites - prochaine échéance 16/06/2016
- Fondation maladies rares - Call 2016 ‘ Preclinical Research in rare diseases: translational steps in large animals’ Development of experimental models and evaluation of therapeutic strategies
Purpose: to support pilot scientific projects at the interface between the in vivo proofs of principle, usually in rodents, and the development of a clinical application in human patients, aiming to improve human well being.
Eligibility: Eligible: Validation of a proof of concept from in vivo model.
Not eligible: Toxicology study.
Funding : 100.000 €
Procedure: two-stage submission: pre-proposals (deadline 28/06/2016) and full proposals (deadline 17/11/2016)
Deadline : 28/06/2016 (17:00)
- National Institutes of Health (NIH) - Understanding HIV Rebound (P01)
Purpose: to support multi-disciplinary, Program Project applications aimed at understanding specific mechanisms, biomarkers, and pathways associated with rebound of HIV viremia.
Budget and duration: Application budgets are limited to $1,000,000 in direct costs. The maximum project period is 5 years.
Letter of Intent due date: June 29, 2016
Deadline : 29/06/2016 (Letter of Intent)
- Leucémie Myéloïde Chronique (LMC) - Appel à projets de recherche
Objectif : promouvoir la recherche dans le domaine de la LMC et à développer la compréhension de cette forme rare du cancer du sang en finançant des projets de recherche :
- s'intégrant dans le cadre de la leucémie myéloïde chronique
- conçus et présentés par une ou plusieurs équipes de biologie ou de recherche fondamentale et/ou une équipe ou un groupe de recherche clinique.
Eligibilité : une ou plusieurs équipes de biologie ou de recherche fondamentale, équipes de recherche clinique: médecins, biologistes, anapathologistes, psychologues, biostatisticiens, jeunes chercheurs scientifiques en cours de thèses ou en stage post-doctorat.
Montant : 20.000 €
Deadline : 30/06/2016
- The French Foundation for rare diseases (Fondation maladies rares) / French National Infrastructure TEFOR Call 2016 : ‘Small animal models and rare diseases’
Purpose: to give a significant boost to the generation and characterization of small animal models of rare diseases, in order to get a better understanding of pathophysiological mechanisms involved in rare diseases and to favor new collaborations between rare diseases research teams and groups with extensive experience with a particular animal model.
Funding: for the generation of the animal model and/or if justified and approved,for the characterization of the model by phenotyping or functional studies. Funding will cover costs of services provided by the platform and is not intended to cover equipment, running costs or personnel costs in the researcher’s laboratory.
Deadline : 05/07/2016 (17:00)
- IMI (Innovative Medicines Initiative) : IMI2 - call 9
The Call includes the following topics:
- Addressing the clinical burden of Clostridium difficile infection (CDI): evaluation of the burden, current practices and set up of a European research platform (part of the IMI New Drugs for Bad Bugs (ND4BB) programme)
- Development of immune tolerance therapies for the treatment of rheumatic diseases
- Data quality in preclinical research and development
- Next generation of electronic translational safety – NEXGETS
- Identification and validation of non-invasive markers across the spectrum of nonalcoholic fatty liver disease (NAFLD)
- Joint influenza vaccine effectiveness surveillance studies Webinars
Why apply?
The Calls for proposals represent an excellent opportunity for researchers to take part in ground-breaking collaborative projects that aim to deliver tangible benefits for patients. Scientists from academia, industry, SMEs, medium-sized companies, hospitals and patients’ organisations are warmly invited to get involved in our projects.
From 11 to 29 April 2016, IMI is holding information webinars on each of the Call topics as well as on IMI rules and procedures.
The registration links, webinar presentations and video recordings can be found online.
Find partners for submitting a proposal:
Get advice on how to find project partners at www.imi.europa.eu/content/partner-search.
Deadline : 26/07/2016
- National Institutes of Health (NIH) - Innovation for HIV Vaccine Discovery (R01)
Purpose: to invite applications proposing innovative, high risk, high impact research to identify novel HIV vaccine concepts and targets. A further focus is to answer important scientific questions that will aid in the design and development of an effective immunogen that may provide long-term safe protection from either acquisition of, or ongoing infection by HIV.
Budget and duration: Application budgets are limited to $350,000 per year in direct costs for up to 4 years.
Application due date: August 1, 2016
Deadline : 01/08/2016
- National Institutes of Health (NIH) - Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01)
Purpose: to encourage transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as “chemobrain.”
Budget and duration: Application budgets should reflect the actual needs of the proposed project. The maximum project period is 5 years.
Application due dates: October 13, 2016; April 11, 2017; October 10, 2017; April 11, 2018; October 10, 2018; April 11, 2019
Deadline : Plusieurs dates limites - prochaine échéance 13/10/2016